These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Cases of borderline in vitro constitutive thyrotropin receptor activity: how to decide whether a thyrotropin receptor mutation is constitutively active or not? Mueller S; Gozu HI; Bircan R; Jaeschke H; Eszlinger M; Lueblinghoff J; Krohn K; Paschke R Thyroid; 2009 Jul; 19(7):765-73. PubMed ID: 19583488 [TBL] [Abstract][Full Text] [Related]
23. Current standards, variations, and pitfalls for the determination of constitutive TSHR activity in vitro. Mueller S; Jaeschke H; Paschke R Methods Enzymol; 2010; 485():421-36. PubMed ID: 21050930 [TBL] [Abstract][Full Text] [Related]
24. A new silent germline mutation of the TSH receptor: coexpression in a hyperthyroid family member with a second activating somatic mutation. Gozu HI; Mueller S; Bircan R; Krohn K; Ekinci G; Yavuzer D; Sargin H; Sargin M; Ones T; Gezen C; Orbay E; Cirakoglu B; Paschke R Thyroid; 2008 May; 18(5):499-508. PubMed ID: 18466076 [TBL] [Abstract][Full Text] [Related]
25. A novel TSHR gene mutation (Ile691Phe) in a Chinese family causing autosomal dominant non-autoimmune hyperthyroidism. Liu Z; Sun Y; Dong Q; He M; Cheng CHK; Fan F J Hum Genet; 2008; 53(5):475-478. PubMed ID: 18306976 [TBL] [Abstract][Full Text] [Related]
26. Sporadic nonautoimmune neonatal hyperthyroidism due to A623V germline mutation in the thyrotropin receptor gene. Aycan Z; Ağladıoğlu SY; Ceylaner S; Cetinkaya S; Baş VN; Kendirici HN J Clin Res Pediatr Endocrinol; 2010; 2(4):168-72. PubMed ID: 21274318 [TBL] [Abstract][Full Text] [Related]
27. A new phenotype of nongoitrous and nonautoimmune hyperthyroidism caused by a heterozygous thyrotropin receptor mutation in transmembrane helix 6. Winkler F; Kleinau G; Tarnow P; Rediger A; Grohmann L; Gaetjens I; Krause G; L'Allemand D; Grüters A; Krude H; Biebermann H J Clin Endocrinol Metab; 2010 Aug; 95(8):3605-10. PubMed ID: 20501679 [TBL] [Abstract][Full Text] [Related]
28. New pathogenic thyrotropin receptor mutations decipher differentiated activity switching at a conserved helix 6 motif of family A GPCR. Biebermann H; Winkler F; Handke D; Teichmann A; Gerling B; Cameron F; Eichhorst J; Grüters A; Wiesner B; Kühnen P; Krude H; Kleinau G J Clin Endocrinol Metab; 2012 Feb; 97(2):E228-32. PubMed ID: 22112806 [TBL] [Abstract][Full Text] [Related]
29. Somatic mutations in the thyrotropin receptor gene and not in the Gs alpha protein gene in 31 toxic thyroid nodules. Führer D; Holzapfel HP; Wonerow P; Scherbaum WA; Paschke R J Clin Endocrinol Metab; 1997 Nov; 82(11):3885-91. PubMed ID: 9360556 [TBL] [Abstract][Full Text] [Related]
30. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Parma J; Duprez L; Van Sande J; Cochaux P; Gervy C; Mockel J; Dumont J; Vassart G Nature; 1993 Oct; 365(6447):649-51. PubMed ID: 8413627 [TBL] [Abstract][Full Text] [Related]
31. The first activating TSH receptor mutation in transmembrane domain 1 identified in a family with nonautoimmune hyperthyroidism. Biebermann H; Schöneberg T; Hess C; Germak J; Gudermann T; Grüters A J Clin Endocrinol Metab; 2001 Sep; 86(9):4429-33. PubMed ID: 11549687 [TBL] [Abstract][Full Text] [Related]
32. Novel TSHR germline mutation (Met463Val) masquerading as Graves' disease in a large Welsh kindred with hyperthyroidism. Fuhrer D; Warner J; Sequeira M; Paschke R; Gregory J; Ludgate M Thyroid; 2000 Dec; 10(12):1035-41. PubMed ID: 11201847 [TBL] [Abstract][Full Text] [Related]
33. Ras homolog enriched in striatum inhibits the functional activity of wild type thyrotropin, follicle-stimulating hormone, luteinizing hormone receptors and activating thyrotropin receptor mutations by altering their expression in COS-7 cells. Agretti P; De Marco G; Pinchera A; Vitti P; Bernal J; Tonacchera M J Endocrinol Invest; 2007 Apr; 30(4):279-84. PubMed ID: 17556863 [TBL] [Abstract][Full Text] [Related]
34. A family with congenital hypothyroidism caused by a combination of loss-of-function mutations in the thyrotropin receptor and adenylate cyclase-stimulating G alpha-protein subunit genes. Lado-Abeal J; Castro-Piedras I; Palos-Paz F; Labarta-Aizpún JI; Albero-Gamboa R Thyroid; 2011 Feb; 21(2):103-9. PubMed ID: 21186955 [TBL] [Abstract][Full Text] [Related]
36. Lack of in vitro constitutive activity for four previously reported TSH receptor mutations identified in patients with nonautoimmune hyperthyroidism and hot thyroid carcinomas. Jaeschke H; Mueller S; Eszlinger M; Paschke R Clin Endocrinol (Oxf); 2010 Dec; 73(6):815-20. PubMed ID: 20846293 [TBL] [Abstract][Full Text] [Related]
37. Deletions in the third intracellular loop of the thyrotropin receptor. A new mechanism for constitutive activation. Wonerow P; Schöneberg T; Schultz G; Gudermann T; Paschke R J Biol Chem; 1998 Apr; 273(14):7900-5. PubMed ID: 9525885 [TBL] [Abstract][Full Text] [Related]
38. Prevalence of mutations in TSHR, GNAS, PRKAR1A and RAS genes in a large series of toxic thyroid adenomas from Galicia, an iodine-deficient area in NW Spain. Palos-Paz F; Perez-Guerra O; Cameselle-Teijeiro J; Rueda-Chimeno C; Barreiro-Morandeira F; Lado-Abeal J; ; Araujo Vilar D; Argueso R; Barca O; Botana M; Cabezas-Agrícola JM; Catalina P; Dominguez Gerpe L; Fernandez T; Mato A; Nuño A; Penin M; Victoria B Eur J Endocrinol; 2008 Nov; 159(5):623-31. PubMed ID: 18694911 [TBL] [Abstract][Full Text] [Related]
39. Sporadic congenital hyperthyroidism due to a spontaneous germline mutation in the thyrotropin receptor gene. Holzapfel HP; Wonerow P; von Petrykowski W; Henschen M; Scherbaum WA; Paschke R J Clin Endocrinol Metab; 1997 Nov; 82(11):3879-84. PubMed ID: 9360555 [TBL] [Abstract][Full Text] [Related]